' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning.
Exeli, AK; Kellner, D; Exeli, L; Steininger, P; Wolf, F; Sedlmayer, F; Deutschmann, H
RADIAT ONCOL. 2018; 13(1): 20
Originalarbeiten (Zeitschrift)


Deutschmann Heinz
Kellner Daniel
Sedlmayer Felix
Steininger Philipp
Wolf Frank


To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may be linked to high doses to the cortex. In a planning study, we investigated the impact of dose constraints to the cerebral cortex and its relation to the organs at risk for glioblastoma patients.

Find related publications in this database (Keywords)

Robust treatment planning
Cortical sparing